Loading...

Advanced Radiotherapeutics Will Capitalize On Aging Cancer Demographics

Published
19 Aug 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-59.3%
7D
-6.6%

Author's Valuation

US$20.597.6% undervalued intrinsic discount

AnalystHighTarget Fair Value